Access to medicines

Child vaccine - photo by Julien Harneis
International standards & introductory material on access to medicines: click here

Articles & reports from a range of sources are below.

Get RSS feed of these results

Related stories and components

Article
14 November 2017

EU: Commission launches public consultation on institutional investors & asset managers' duties regarding sustainability, incl. human rights

Author: European Commission

...

Read more

Article
28 September 2017
+ Español - Hide

Author: El Espectador

“Se buscan médicos sin conflictos de interés” - 21 de septiembre de 2017...

Read more

Article
17 August 2017

Inside the C.E.O. Rebellion Against Trump’s Advisory Councils

Author: David Gelles, Landon Thomas Jr., Andrew Ross Sorkin & Kate Kellyaug, NY Times (USA)

On Tuesday, Indra Nooyi, the chief executive of PepsiCo, joined a call with other prominent corporate chieftains who...had agreed to advise...Trump. A rebellion was brewing. Along with other business leaders, [she]...watched with bafflement over the...

Read more

Article
9 July 2017

UK drugs groups seek court block on NHS price limits

Author: Sarah Neville, Financial Times (UK)

The UK drugs industry is going to court in an attempt to stop the country’s taxpayer-funded National Health Service from imposing new limits on the price it will pay for medicines. The action follows a government crackdown in April that limits funding...

Read more

Article
26 May 2017
+ Français - Hide

Author: Ram Etwareea, Le Temps (Suisse)

« Novartis attaque la Colombie en justice », 23 mai 2017...

Read more

Article
19 April 2017
+ Français - Hide

Author: Bilan (Suisse)

« Novartis accusé de pression sur la Colombie », 12 avril 2017...

Read more

Article
12 April 2017

Colombia: Leaked documents reveal Novartis threatened govt. with intl. investment arbitration over licensing of pharmaceutical patents

Author: Public Eye

"Compulsory licensing in Colombia: Leaked documents show aggressive lobbying by Novartis", 11 Apr 2017...

Read more

Article
6 February 2017

Commentary: Embracing access to medicines can be beneficial for pharmaceutical companies' business & reputation

Author: Damiano de Felice, Access to Medicines Index, on Harvard Business Review

"How Pharma Can Fix Its Reputation and Its Business at the Same Time", 3 Feb 2017...

Read more

Article
31 January 2017

USA: Diabetes patients sue Novo Nordisk, Sanofi, & Eli Lilly for alleged insulin price-fixing

Author: Lydia Ramsey, Business Insider (UK)

"The makers of insulin are being accused of price-fixing in a class-action lawsuit", 30 Jan 2017...

Read more

Article
26 January 2017
+ Português - Hide

Author: Grupo de Trabalho sobre Propriedade Intelectual-GTPI (Brazil)

“INPI rejeita pedido de patente do Truvada® no Brasil-Com a decisão, a combinação de medicamentos que atua na prevenção do HIV passa a fazer parte do domínio público”, 24 de janeiro de 2017...

Read more